Global Immunotherapy Drugs Market Professional Survey Report 2016
- QYR629467
- 119 Pages
- July 2016
- Pharmaceuticals
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Merck-Pfizer
Eli Lilly
Amgen
Roche
Bristol Myers Squibb
Dendreon (Valeant)
Novartis
Seattle Genetics
Celgene
AstraZeneca
Northwest Biotherapeutics
By types, the market can be split into
Specific Cancer Immunotherapy Drugs
Non-Specific Cancer Immunotherapy Drugs
Type III
By Application, the market can be split into
Leukemia Treatment
Colorectal Cancer Treatment
Other Cancer Treatment
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global Immunotherapy Drugs Market Professional Survey Report 2016
1 Industry Overview of Immunotherapy Drugs
1.1 Definition and Specifications of Immunotherapy Drugs
1.1.1 Definition of Immunotherapy Drugs
1.1.2 Specifications of Immunotherapy Drugs
1.2 Classification of Immunotherapy Drugs
1.2.1 Specific Cancer Immunotherapy Drugs
1.2.2 Non-Specific Cancer Immunotherapy Drugs
1.2.3 Type III
1.3 Applications of Immunotherapy Drugs
1.3.1 Leukemia Treatment
1.3.2 Colorectal Cancer Treatment
1.3.3 Other Cancer Treatment
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Immunotherapy Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Immunotherapy Drugs
2.3 Manufacturing Process Analysis of Immunotherapy Drugs
2.4 Industry Chain Structure of Immunotherapy Drugs
3 Technical Data and Manufacturing Plants Analysis of Immunotherapy Drugs
3.1 Capacity and Commercial Production Date of Global Immunotherapy Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Immunotherapy Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Immunotherapy Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Immunotherapy Drugs Major Manufacturers in 2015
4 Global Immunotherapy Drugs Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global Immunotherapy Drugs Capacity and Growth Rate Analysis
4.2.2 2015 Immunotherapy Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global Immunotherapy Drugs Sales and Growth Rate Analysis
4.3.2 2015 Immunotherapy Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global Immunotherapy Drugs Sales Price
4.4.2 2015 Immunotherapy Drugs Sales Price Analysis (Company Segment)
5 Immunotherapy Drugs Regional Market Analysis
5.1 North America Immunotherapy Drugs Market Analysis
5.1.1 North America Immunotherapy Drugs Market Overview
5.1.2 North America 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Immunotherapy Drugs Sales Price Analysis
5.1.4 North America 2015 Immunotherapy Drugs Market Share Analysis
5.2 China Immunotherapy Drugs Market Analysis
5.2.1 China Immunotherapy Drugs Market Overview
5.2.2 China 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Immunotherapy Drugs Sales Price Analysis
5.2.4 China 2015 Immunotherapy Drugs Market Share Analysis
5.3 Europe Immunotherapy Drugs Market Analysis
5.3.1 Europe Immunotherapy Drugs Market Overview
5.3.2 Europe 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Immunotherapy Drugs Sales Price Analysis
5.3.4 Europe 2015 Immunotherapy Drugs Market Share Analysis
5.4 Southeast Asia Immunotherapy Drugs Market Analysis
5.4.1 Southeast Asia Immunotherapy Drugs Market Overview
5.4.2 Southeast Asia 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E Immunotherapy Drugs Sales Price Analysis
5.4.4 Southeast Asia 2015 Immunotherapy Drugs Market Share Analysis
5.5 Japan Immunotherapy Drugs Market Analysis
5.5.1 Japan Immunotherapy Drugs Market Overview
5.5.2 Japan 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Immunotherapy Drugs Sales Price Analysis
5.5.4 Japan 2015 Immunotherapy Drugs Market Share Analysis
5.6 India Immunotherapy Drugs Market Analysis
5.6.1 India Immunotherapy Drugs Market Overview
5.6.2 India 2011-2016E Immunotherapy Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Immunotherapy Drugs Sales Price Analysis
5.6.4 India 2015 Immunotherapy Drugs Market Share Analysis
6 Global 2011-2016E Immunotherapy Drugs Segment Market Analysis (by Type)
6.1 Global 2011-2016E Immunotherapy Drugs Sales by Type
6.2 Different Types of Immunotherapy Drugs Product Interview Price Analysis
6.3 Different Types of Immunotherapy Drugs Product Driving Factors Analysis
6.3.1 Specific Cancer Immunotherapy Drugs of Immunotherapy Drugs Growth Driving Factor Analysis
6.3.2 Non-Specific Cancer Immunotherapy Drugs of Immunotherapy Drugs Growth Driving Factor Analysis
6.3.3 Type III Immunotherapy Drugs Growth Driving Factor Analysis
7 Global 2011-2016E Immunotherapy Drugs Segment Market Analysis (by Application)
7.1 Global 2011-2016E Immunotherapy Drugs Consumption by Application
7.2 Different Application of Immunotherapy Drugs Product Interview Price Analysis
7.3 Different Application of Immunotherapy Drugs Product Driving Factors Analysis
7.3.1 Leukemia Treatment of Immunotherapy Drugs Growth Driving Factor Analysis
7.3.2 Colorectal Cancer Treatment of Immunotherapy Drugs Growth Driving Factor Analysis
7.3.3 Other Cancer Treatment of Immunotherapy Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Immunotherapy Drugs
8.1 Merck-Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Merck-Pfizer 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Merck-Pfizer 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.2 Eli Lilly
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Eli Lilly 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eli Lilly 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.3 Amgen
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Amgen 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Amgen 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.4 Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Roche 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Roche 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.5 Bristol Myers Squibb
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Bristol Myers Squibb 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Bristol Myers Squibb 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.6 Dendreon (Valeant)
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Dendreon (Valeant) 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Dendreon (Valeant) 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.7 Novartis
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Novartis 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novartis 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.8 Seattle Genetics
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Seattle Genetics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Seattle Genetics 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.9 Celgene
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Celgene 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Celgene 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.10 AstraZeneca
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 AstraZeneca 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 AstraZeneca 2015 Immunotherapy Drugs Business Region Distribution Analysis
8.11 Northwest Biotherapeutics
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Northwest Biotherapeutics 2015 Immunotherapy Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Northwest Biotherapeutics 2015 Immunotherapy Drugs Business Region Distribution Analysis
9 Development Trend of Analysis of Immunotherapy Drugs Market
9.1 Global Immunotherapy Drugs Market Trend Analysis
9.1.1 Global 2016-2021 Immunotherapy Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Immunotherapy Drugs Sales Price Forecast
9.2 Immunotherapy Drugs Regional Market Trend
9.2.1 North America 2016-2021 Immunotherapy Drugs Consumption Forecast
9.2.2 China 2016-2021 Immunotherapy Drugs Consumption Forecast
9.2.3 Europe 2016-2021 Immunotherapy Drugs Consumption Forecast
9.2.4 Southeast Asia 2016-2021 Immunotherapy Drugs Consumption Forecast
9.2.5 Japan 2016-2021 Immunotherapy Drugs Consumption Forecast
9.2.6 India 2016-2021 Immunotherapy Drugs Consumption Forecast
9.3 Immunotherapy Drugs Market Trend (Product Type)
9.4 Immunotherapy Drugs Market Trend (Application)
10 Immunotherapy Drugs Marketing Type Analysis
10.1 Immunotherapy Drugs Regional Marketing Type Analysis
10.2 Immunotherapy Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Immunotherapy Drugs by Regions
10.4 Immunotherapy Drugs Supply Chain Analysis
11 Consumers Analysis of Immunotherapy Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Immunotherapy Drugs Market Professional Survey Report 2016
Figure Picture of Immunotherapy Drugs
Table Product Specifications of Immunotherapy Drugs
Table Classification of Immunotherapy Drugs
Figure Global Production Market Share of Immunotherapy Drugs by Type in 2015
Figure Specific Cancer Immunotherapy Drugs Picture
Table Major Manufacturers of Specific Cancer Immunotherapy Drugs
Figure Non-Specific Cancer Immunotherapy Drugs Picture
Table Major Manufacturers of Non-Specific Cancer Immunotherapy Drugs
Table Applications of Immunotherapy Drugs
Figure Global Consumption Volume Market Share of Immunotherapy Drugs by Application in 2015
Figure Leukemia Treatment Examples
Table Major Consumers of Leukemia Treatment
Figure Colorectal Cancer Treatment Examples
Table Major Consumers of Colorectal Cancer Treatment
Figure Other Cancer Treatment Examples
Table Major Consumers of Other Cancer Treatment
Figure Market Share of Immunotherapy Drugs by Regions
Figure North America Immunotherapy Drugs Market Size (2011-2021)
Figure China Immunotherapy Drugs Market Size (2011-2021)
Figure Europe Immunotherapy Drugs Market Size (2011-2021)
Figure Southeast Asia Immunotherapy Drugs Market Size (2011-2021)
Figure Japan Immunotherapy Drugs Market Size (2011-2021)
Figure India Immunotherapy Drugs Market Size (2011-2021)
Table Immunotherapy Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Immunotherapy Drugs in 2015
Figure Manufacturing Process Analysis of Immunotherapy Drugs
Figure Industry Chain Structure of Immunotherapy Drugs
Table Capacity (K Units) and Commercial Production Date of Global Immunotherapy Drugs Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Immunotherapy Drugs Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Immunotherapy Drugs Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Immunotherapy Drugs Major Manufacturers in 2015
Table Global Capacity (K Units) , Sales (K Units) , Price (USD/Unit) , Cost (USD/Unit) , Sales Revenue (M USD) and Gross Margin of Immunotherapy Drugs 2011-2016
Figure Global 2011-2016E Immunotherapy Drugs Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Immunotherapy Drugs Market Size (Value) and Growth Rate
Table 2011-2016E Global Immunotherapy Drugs Capacity and Growth Rate
Table 2015 Global Immunotherapy Drugs Capacity List (Company Segment)
Table 2011-2016E Global Immunotherapy Drugs Sales and Growth Rate
Table 2015 Global Immunotherapy Drugs Sales List (Company Segment)
Table 2011-2016E Global Immunotherapy Drugs Sales Price
Table 2015 Global Immunotherapy Drugs Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Immunotherapy Drugs 2011-2016 (K Units)
Figure North America 2011-2016E Immunotherapy Drugs Sales Price (USD/Unit)
Figure North America 2015 Immunotherapy Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Immunotherapy Drugs 2011-2016 (K Units)
Figure China 2011-2016E Immunotherapy Drugs Sales Price (USD/Unit)
Figure China 2015 Immunotherapy Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Immunotherapy Drugs 2011-2016 (K Units)
Figure Europe 2011-2016E Immunotherapy Drugs Sales Price (USD/Unit)
Figure Europe 2015 Immunotherapy Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Immunotherapy Drugs 2011-2016 (K Units)
Figure Southeast Asia 2011-2016E Immunotherapy Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2015 Immunotherapy Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Immunotherapy Drugs 2011-2016 (K Units)
Figure Japan 2011-2016E Immunotherapy Drugs Sales Price (USD/Unit)
Figure Japan 2015 Immunotherapy Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Immunotherapy Drugs 2011-2016 (K Units)
Figure India 2011-2016E Immunotherapy Drugs Sales Price (USD/Unit)
Figure India 2015 Immunotherapy Drugs Sales Market Share
Table Global 2011-2016E Immunotherapy Drugs Sales by Type
Table Different Types Immunotherapy Drugs Product Interview Price
Table Global 2011-2016E Immunotherapy Drugs Sales by Application
Table Different Application Immunotherapy Drugs Product Interview Price
Table Merck-Pfizer Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Merck-Pfizer Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Merck-Pfizer 2015 Immunotherapy Drugs Business Region Distribution
Table Eli Lilly Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Eli Lilly Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly 2015 Immunotherapy Drugs Business Region Distribution
Table Amgen Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Amgen Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Amgen 2015 Immunotherapy Drugs Business Region Distribution
Table Roche Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Roche Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Immunotherapy Drugs Business Region Distribution
Table Bristol Myers Squibb Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Bristol Myers Squibb Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Bristol Myers Squibb 2015 Immunotherapy Drugs Business Region Distribution
Table Dendreon (Valeant) Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Dendreon (Valeant) Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Dendreon (Valeant) 2015 Immunotherapy Drugs Business Region Distribution
Table Novartis Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Novartis Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Novartis 2015 Immunotherapy Drugs Business Region Distribution
Table Seattle Genetics Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Seattle Genetics Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Seattle Genetics 2015 Immunotherapy Drugs Business Region Distribution
Table Celgene Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Celgene Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Celgene 2015 Immunotherapy Drugs Business Region Distribution
Table AstraZeneca Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 AstraZeneca Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 AstraZeneca 2015 Immunotherapy Drugs Business Region Distribution
Table Northwest Biotherapeutics Information List
Table Type I Immunotherapy Drugs Overview
Table Type II Immunotherapy Drugs Overview
Table Type III Immunotherapy Drugs Overview
Table 2015 Northwest Biotherapeutics Immunotherapy Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Northwest Biotherapeutics 2015 Immunotherapy Drugs Business Region Distribution
Figure Global 2016-2021 Immunotherapy Drugs Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Immunotherapy Drugs Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Immunotherapy Drugs Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Immunotherapy Drugs Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Units) of Immunotherapy Drugs by Types 2016-2021
Table Global Consumption Volume (K Units) of Immunotherapy Drugs by Applications 2016-2021
Table Traders or Distributors with Contact Information of Immunotherapy Drugs by Regions
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
